Regeneron Pharmaceuticals
REGN
#231
Rank
$77.12 B
Marketcap
$701.85
Share price
-0.90%
Change (1 day)
-16.62%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - P/B ratio

P/B ratio as of December 2024 : 2.66

According to Regeneron Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 5.63263.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Regeneron Pharmaceuticals - P/B ratio (from 2001 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-312.86-22.4%
2023-12-313.686.27%
2022-12-313.47-4.19%
2021-12-313.62-22.61%
2020-12-314.6825.23%
2019-12-313.73-19.69%
2018-12-314.65-29.28%
2017-12-316.57-24.45%
2016-12-318.70-44.02%
2015-12-3115.5-5.67%
2014-12-3116.517.23%
2013-12-3114.15.17%
2012-12-3113.426.5%
2011-12-3110.689.94%
2010-12-315.5612.52%
2009-12-314.9442.48%
2008-12-313.47-16.15%
2007-12-314.14-31.72%
2006-12-316.06-23.02%
2005-12-317.87179.3%
2004-12-312.82-52.54%
2003-12-315.945.23%
2002-12-315.64

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
19.0 615.74%๐Ÿ‡บ๐Ÿ‡ธ USA
979 36,713.59%๐Ÿ‡บ๐Ÿ‡ธ USA
1.31-50.90%๐Ÿ‡บ๐Ÿ‡ธ USA
4.97 86.69%๐Ÿ‡บ๐Ÿ‡ธ USA
4.47 68.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
1.55-41.69%๐Ÿ‡ซ๐Ÿ‡ท France